Ethical considerations of biomarker use in prodromal Alzheimer’s disease
Diagnosing earlier in Alzheimer's disease
Are we making progress in dementia treatment?
A framework for easy access to Alzheimer's disease data
Pieter Jelle Visser
Microglial proteins in the brain: the good, the bad and the ugly